Atantares
PrivateLast Round
Early Funding
Aug 2, 2023
Total Funding Raised
$13.9M
Company Overview
Atantares operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was an Early Funding round in August 2023.
Atantares is a biotechnology company that develops molecular chips and high-throughput DNA synthesis platforms by integrating semiconductor and microfluidic technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Semiconductors, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atantares Comparables
Compare Atantares with similar companies based on industry and business-model similarity.
No comparables are published for Atantares. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Atantares Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 2, 2023 | ||||
| Pre Seed | Aug 2, 2023 | ||||
| Angel | May 6, 2022 | ||||
| Accelerator | May 19, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Atantares Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frees Fund | Pre Seed, Angel |
| Asia Green Fund | Pre Seed |
| Qiming Venture Partners | Pre Seed, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2025
Monthly visitors grew 121% MoM.
- Aug 2, 2023
Secured funding from Alibaba Health Information Technology Limited.
For institutional investors. Book with your work email.
Atantares Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atantares's valuation, stock price, and market status.
Is Atantares a public or private company?
Atantares is a private company.
What is the current stock price of Atantares?
Atantares is a private company, so its shares have no public market price. Caplight tracks Atantares's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atantares worth (valuation)?
Valuation information for Atantares is not publicly available.
Can I buy Atantares stock?
Atantares shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atantares's last funding round?
Atantares's most recent funding round was Early Funding on August 2, 2023.
Who are the main investors in Atantares?
Key investors in Atantares include Asia Green Fund, Qiming Venture Partners.
Will Atantares IPO soon?
No public IPO plans have been announced for Atantares.
How can I track Atantares secondary market activity?
Caplight tracks bids, offers, and trades in Atantares's shares on secondary markets.